Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.47 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.47 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2062103 | 1.00 | SMN1; SMN2 (0.64) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL1496409 | 0.88 | SMN1; SMN2 (0.60) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL7723906 | 0.86 | SMN1; SMN2 (0.68) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL426382 | 0.85 | SMN1; SMN2 (0.67) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL26870536 | 0.84 | SMN1; SMN2 (0.49) | SMN1; SMN2MAPTALDH1A1KMT2ATP53 | |
| SCHEMBL14567836 | 0.84 | SMN1; SMN2 (0.49) | SMN1; SMN2MAPTALDH1A1KMT2ALMNA | |
| SCHEMBL30686809 | 0.84 | SMN1; SMN2 (0.49) | SMN1; SMN2MAPTALDH1A1KMT2ALMNA | |
| SCHEMBL5925545 | 0.84 | SMN1; SMN2 (0.65) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL6750268 | 0.84 | SMN1; SMN2 (0.65) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL9080448 | 0.83 | SMN1; SMN2 (0.55) | SMN1; SMN2MAPTALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226228-A1 | POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226228-A1 | POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION | TLR5, SLC10A2, FNTB | SMN1; SMN2 3077/4885MAPT 778/4885ALDH1A1 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.